Patent · US Active

Nucleic acids encoding IL-22 Fc fusion proteins

US10087227B2 · kind B2 · utility

3Cited by
54References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 5, 2016
Grant dateOct 2, 2018
Priority date
Expiry dateDec 5, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to IL-22 polypeptides, IL-22 Fc fusion proteins and IL-22 agonists, composition comprising the same, methods of making and methods of using the composition for the treatment of diseases. The invention also relates to IL-22 receptor associated reagents and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.